MX9304642A - Nuevo compuesto. - Google Patents

Nuevo compuesto.

Info

Publication number
MX9304642A
MX9304642A MX9304642A MX9304642A MX9304642A MX 9304642 A MX9304642 A MX 9304642A MX 9304642 A MX9304642 A MX 9304642A MX 9304642 A MX9304642 A MX 9304642A MX 9304642 A MX9304642 A MX 9304642A
Authority
MX
Mexico
Prior art keywords
new compound
activity
furiltiazole
ulcerative
humans
Prior art date
Application number
MX9304642A
Other languages
English (en)
Inventor
Tetsuo Tomishi
Hisashi Takasugi
Yousuke Katsura
Yoshikazu Inoue
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919116736A external-priority patent/GB9116736D0/en
Priority claimed from GB929208734A external-priority patent/GB9208734D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of MX9304642A publication Critical patent/MX9304642A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

Esta invención se relaciona con derivados furiltiazol representados por la siguiente fórmula: (Ver Fórmula) en la que cada símbolo es como se define en la especificación y sus sales farmacéuticamente aceptables las cuales tienen actividad antiulcerosa, antagonismo del receptor H2 y actividad antimicrobiana, con procesos para la preparación de los mismos, con una composición farmacéutica que comprende a los mismos y con un método para el tratamiento de enfermedades ulcerativas e infecciosas en seres humanos o animales.
MX9304642A 1991-08-02 1992-08-03 Nuevo compuesto. MX9304642A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919116736A GB9116736D0 (en) 1991-08-02 1991-08-02 New compound
GB929208734A GB9208734D0 (en) 1992-04-22 1992-04-22 New compound
PCT/JP1992/000986 WO1993003028A1 (en) 1991-08-02 1992-08-03 Furylthiazole and their use as h2-receptor antagonism and antimicrobial

Publications (1)

Publication Number Publication Date
MX9304642A true MX9304642A (es) 1994-02-28

Family

ID=26299345

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304642A MX9304642A (es) 1991-08-02 1992-08-03 Nuevo compuesto.

Country Status (10)

Country Link
US (1) US5512588A (es)
EP (1) EP0598906A1 (es)
JP (1) JPH06509353A (es)
CN (1) CN1097010A (es)
AU (1) AU4760093A (es)
CA (1) CA2114651A1 (es)
IL (1) IL106433A0 (es)
MX (1) MX9304642A (es)
WO (2) WO1993003028A1 (es)
ZA (1) ZA935320B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0598906A1 (en) * 1991-08-02 1994-06-01 Fujisawa Pharmaceutical Co., Ltd. Furylthiazole and their use as h 2?-receptor antagonism and antimicrobial
GB9311613D0 (en) * 1993-06-04 1993-07-21 Fujisawa Pharmaceutical Co Thienylthiazole derivatives
GB9326611D0 (en) * 1993-12-31 1994-03-02 Fujisawa Pharmaceutical Co New compound
DE102004008141A1 (de) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
IL91152A0 (en) * 1988-08-15 1990-03-19 Fujisawa Pharmaceutical Co Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5308857A (en) * 1988-08-15 1994-05-03 Fujisawa Pharmaceutical Co., Ltd. Furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0598906A1 (en) * 1991-08-02 1994-06-01 Fujisawa Pharmaceutical Co., Ltd. Furylthiazole and their use as h 2?-receptor antagonism and antimicrobial

Also Published As

Publication number Publication date
WO1994003450A1 (en) 1994-02-17
AU4760093A (en) 1994-03-03
CA2114651A1 (en) 1993-02-18
IL106433A0 (en) 1993-11-15
CN1097010A (zh) 1995-01-04
US5512588A (en) 1996-04-30
WO1993003028A1 (en) 1993-02-18
JPH06509353A (ja) 1994-10-20
ZA935320B (en) 1994-02-15
EP0598906A1 (en) 1994-06-01

Similar Documents

Publication Publication Date Title
UY27092A1 (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
UY29633A1 (es) Derivados de oxindol
UY28510A1 (es) Compuestos quimicos
ES2087916T3 (es) Derivado de pirimidina biciclico, metodo para producir el mismo, y preparacion farmaceutica que contiene el mismo como ingrediente activo.
PA8591701A1 (es) Derivados de pirrolopirimidina
BRPI0513717A (pt) derivados de piridina
UY26782A1 (es) Derivados del benzotiazol
ES2064130T3 (es) Utilizacion de droloxifeno para el tratamiento de enfermedades de los huesos.
AR035792A1 (es) Compuestos de n-(4-quinazolinil)-n-(1h-indazol-5-il) amina, inhibidor de la rho-quinasa, su uso para la fabricacion de un medicamento y metodo para prepararlo
BRPI0507755A (pt) composto de pirazolina substituìda, processo para a sua manufatura, medicamentos e seus usos
ECSP066643A (es) PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS COMO INHIBIDORES DE PDE 2
BRPI0507790A (pt) composto de pirazolina substituìda, processo para a sua manufatura, medicamentos e seus usos
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
PA8487601A1 (es) Derivados biciclicos sustituidos utiles como agentes contra el cancer
CR10327A (es) "PIRIDIN(3-4-b) PIRAZINONAS"
DOP2006000205A (es) Derivados de fenil-1,2,4-oxadiazolona con grupo fenilo, procedimientos para su preparacion y su uso como productos farmaceuticos.
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
BRPI0517792A (pt) macrolonas - quinolonas amino-substituìdas
AR013001A1 (es) Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina.
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
MX9201564A (es) Derivados de biguanida, metodo para fabricar los mismos, y desinfectantes que contienen los derivados.
ECSP088967A (es) Agonistas del receptor muscarínico que son efectivos en el tratamiento del dolor, la enfermedad de alzheimer y la esquizofrenia
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.